Wealthfront Advisers LLC Pacific Biosciences Of California, Inc. Transaction History
Wealthfront Advisers LLC
- $34.9 Billion
- Q1 2025
A detailed history of Wealthfront Advisers LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Wealthfront Advisers LLC holds 89,576 shares of PACB stock, worth $89,576. This represents 0.0% of its overall portfolio holdings.
Number of Shares
89,576
Previous 37,751
137.28%
Holding current value
$89,576
Previous $69,000
52.17%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PACB
# of Institutions
259Shares Held
227MCall Options Held
2.15MPut Options Held
967K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36.5MShares$36.5 Million0.46% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$23.6 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$23.4 Million4.62% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V821.9MShares$21.9 Million0.46% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$20.5 Million0.08% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $225M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...